Efficacy and Safety Study of the HS-25 Combination With Atorvastatin in Subjects With Hypercholesterolemia in Coronary Heart Diseases

NCT03433196 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

255

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia in Coronaory Heart Disease

Interventions

DRUG: HS-25 and Atorvastatin
DRUG: Atorvastatin

Sponsor

Zhejiang Hisun Pharmaceutical Co. Ltd.